Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Human Genome Sciences acquires Principia Pharma for $135mm

Executive Summary

Just a week after filing a shelf registration to raise up to $1bn, Human Genome Sciences acquired private development-stage pharmaceutical company Principia in a stock-for-stock transaction valued at $135mm. HGS issued 1.58mm common shares valued at $82.23 each.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Stock
    • Intra-Biotech Deal
    • Full Acquisition
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register